Treatment of Acute Pancreatitis in Infected Pancreatic Necrosis

Infected pancreatic necrosis is a serious complication of acute pancreatitis that shifts management significantly from the approach used in sterile disease. Identifying this sub-population correctly is essential — the treatment strategy is distinct and more targeted.

Clinical Scenario

Unlike sterile necrosis — where antibiotics are not indicated — infected pancreatic necrosis requires antimicrobial therapy as an essential component of management, alongside careful planning around debridement or necrosectomy.

Treatment Approach (partial overview)

Management centres on antibiotic agents chosen specifically for their ability to penetrate necrotic pancreatic tissue, with the timing of surgical intervention determined by the patient's clinical stability. The full protocol defines selection criteria, the staging approach, and the thresholds that guide further intervention.

Clinical Goal

Complete resolution of the infection with antibiotics — enabling some patients to avoid drainage procedures altogether.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.14309/ajg.0000000000002645

While antibiotics should not be used in patients with sterile necrosis, antibiotics are an important part of treatment in infected necrosis along with debridement/necrosectomy.

Because the infection will likely seed the necrosis, and the necrosis will be difficult to penetrate, antibiotics chosen should be known to penetrate the necrosis, such as carbapenems, quinolones, cephalosporins, and metronidazole.

However, in most patients, those clinically stable, the initial management of infected necrosis should be a 30-day course of antibiotics before surgery to allow the inflammatory reaction to become better organized.

Some patients may avoid drainage altogether because the infection may completely resolve with antibiotics.

View source ↗